Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Incorporating estimands into meta-analyses of clinical trials
Research synthesis methods, 2026;:1-28
Outpatient Dispensing Patterns and Changes in Tirzepatide Strength Mix in Japan: A Study Using the National Open Claims Data
Cureus, 2026;18(7):e113681
Prescription Sequence Symmetry Analysis of Glucagon-Like Peptide-1 Receptor Agonists and Neuropsychiatric Conditions
Clinical pharmacology and therapeutics, 2026
Impurities and Potential Immunogenicity Associated With Follow-on and Compounded Glucagon-like Peptide-1 Receptor Agonists
Pharmaceutical research, 2026
Concurrent initiation of tirzepatide and biologics improves patient-reported outcomes in obese psoriatic arthritis: a propensity score-matched study
RMD open, 2026;12(3)
Adipose Tissue Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease
Cells, 2026;15(15)
Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, and Atrial Fibrillation: An Umbrella Review With Methodological Appraisal of Overlapping Meta-Analyses
Cureus, 2026;18(7):e113641
Multisystem Benefits of GLP-1 Microdosing: A Narrative Review
Cureus, 2026;18(7):e113635
Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial
The American journal of psychiatry, 2026;:appiajp20260003
PYY3-36 potentiates Semaglutide‑mediated mitochondrial modulation in MASLD
American journal of physiology. Endocrinology and metabolism, 2026
Stable pentadecapeptide therapy counteracts gentamicin-induced nephrotoxicity via nitric oxide-system modulation: evidence from a triple nitric oxide-agent approach in rats
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2026;77(3):377-395
Glucagon-like Peptide-1 Receptor Agonists and Chronic Pain: Preclinical Antinociceptive Mechanisms, Indirect Metabolic-Functional Effects, and Clinical Considerations-A Narrative Review
Journal of clinical medicine, 2026;15(15)
Semaglutide improves MASLD and MASH in people with HIV: The SLIM LIVER study
HIV medicine, 2026
A Novel Microfluidic Strategy for the Fabrication of α-Lactalbumin Nanomicelles Paves a New Path for Antiobesity Technology
Advanced healthcare materials, 2026;:e71486
Dose-dependent effects of oral semaglutide on arterial stiffness and the additive role of SGLT-2 inhibitors in type 2 diabetes
British journal of clinical pharmacology, 2026
Low-Dose Tirzepatide for Obesity: Comparative Efficacy of 2.5 mg Versus 5 mg in Non-Diabetic Japanese Adults
Diabetes, obesity & metabolism, 2026
Comment on “Real-world effectiveness of oral semaglutide on body weight, composition, and metabolic parameters in patients with obesity without diabetes”
Medicina clinica, 2026;166(10):107573
Incretin-based therapies, alcohol and tobacco use, and acute substance-related events: emerging implications for cardiovascular medicine
Journal of cardiovascular pharmacology, 2026
Beyond glycemic control: clinical cardiovascular effects of tirzepatide-a narrative review
Therapeutic advances in endocrinology and metabolism, 2026;17:20420188261469947
Lithium and GLP-1-based therapies in bipolar disorder: an emerging pharmacovigilance signal and monitoring considerations
International clinical psychopharmacology, 2026